Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

5.450 USD +0.160 (+3.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,826,664
Open 5.290
Bid (Size) 5.450 (34)
Ask (Size) 5.490 (1)
Prev. Close 5.290
Today's Range 5.230 - 5.480
52wk Range 2.500 - 5.950
Shares Outstanding 222,441,009
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Agenus to Participate in the BTIG Virtual Biotechnology Conference 2021
From GlobeNewswire News Releases
MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
From GlobeNewswire News Releases

Performance

YTD
+68.73%
+68.73%
1 Month
+1.30%
+1.30%
3 Month
+84.12%
+84.12%
6 Month
+28.84%
+28.84%
1 Year
+67.18%
+67.18%

More News

Read More
Agenus to Provide Corporate Update and Second Quarter 2021 Financial Report
From GlobeNewswire News Releases
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
From GlobeNewswire News Releases
VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides Corporate Update
From Business Wire News Releases
Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
From GlobeNewswire News Releases
Bristol Myers Squibb Reports Second Quarter Financial Results for 2021
From Business Wire News Releases
Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration
From PR Newswire
Agenus to Participate in the Raymond James 2021 Human Health Innovation Conference
From GlobeNewswire News Releases
Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer
From GlobeNewswire News Releases
Agenus Announces Virtual Annual Shareholders Meeting
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.